Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction.
about
Treating the dysfunctional placenta.Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy.Fetal therapy for Down syndrome: an ethical exploration.The Legal Frameworks that Govern Fetal Surgery in the United Kingdom, European Union and the United States.
P2860
Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ethics and social acceptabilit ...... nset fetal growth restriction.
@en
type
label
Ethics and social acceptabilit ...... nset fetal growth restriction.
@en
prefLabel
Ethics and social acceptabilit ...... nset fetal growth restriction.
@en
P2093
P2860
P356
P1476
Ethics and social acceptabilit ...... nset fetal growth restriction.
@en
P2093
EVERREST Consortium
M Sheppard
R Ashcroft
R N Spencer
P2860
P304
P356
10.1002/UOG.15880
P577
2016-03-09T00:00:00Z